Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2013 1
2020 1
2023 2
2024 1
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study.
Qin S, Chan SL, Gu S, Bai Y, Ren Z, Lin X, Chen Z, Jia W, Jin Y, Guo Y, Hu X, Meng Z, Liang J, Cheng Y, Xiong J, Ren H, Yang F, Li W, Chen Y, Zeng Y, Sultanbaev A, Pazgan-Simon M, Pisetska M, Melisi D, Ponomarenko D, Osypchuk Y, Sinielnikov I, Yang TS, Liang X, Chen C, Wang L, Cheng AL, Kaseb A, Vogel A; CARES-310 Study Group. Qin S, et al. Among authors: sultanbaev a. Lancet. 2023 Sep 30;402(10408):1133-1146. doi: 10.1016/S0140-6736(23)00961-3. Epub 2023 Jul 24. Lancet. 2023. PMID: 37499670 Clinical Trial.
Darolutamide in Combination With Androgen-Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer From the Phase III ARANOTE Trial.
Saad F, Vjaters E, Shore N, Olmos D, Xing N, Pereira de Santana Gomes AJ, Cesar de Andrade Mota A, Salman P, Jievaltas M, Ulys A, Jakubovskis M, Kopyltsov E, Han W, Nevalaita L, Testa I, Le Berre MA, Kuss I, Haresh KP; ARANOTE Study Investigators. Saad F, et al. J Clin Oncol. 2024 Dec 20;42(36):4271-4281. doi: 10.1200/JCO-24-01798. Epub 2024 Sep 16. J Clin Oncol. 2024. PMID: 39279580 Free PMC article. Clinical Trial.
Maintenance Therapy With Avelumab for Patients With Metastatic Urothelial Carcinoma: A Real-World, Ambispective RAVE-Bladder Study.
Tsimafeyeu I, Gridneva Y, Sultanbaev A, Anzhiganova Y, Gluzman M, Mochalova A, Shkurat A, Israelyan E, Parsadanova E, Murzina Y, Ivanov A, Kalpinskiy A, Stativko O, Petkau V, Karabina E, Kеln A, Tovbik N, Safina S, Turganova M, Kopyltsov E, Bragina V, Novikova O, Lebedinets A, Vodolazskiy V, Rumyantsev A, Zukov R, Pokataev I, Orlova R, Volkova M. Tsimafeyeu I, et al. Among authors: sultanbaev a. Cancer Med. 2025 Feb;14(4):e70636. doi: 10.1002/cam4.70636. Cancer Med. 2025. PMID: 39950261 Free PMC article.
Maintenance avelumab in metastatic urothelial carcinoma: do tumour site and previous surgery matter?
Zukov R, Gridneva Y, Anzhiganova Y, Sultanbaev A, Gluzman M, Mochalova A, Shkurat A, Israelyan E, Parsadanova E, Murzina Y, Ivanov A, Kalpinskiy A, Stativko O, Petkau V, Karabina E, Kеln A, Tovbik N, Safina S, Turganova M, Kopyltsov E, Bragina V, Novikova O, Lebedinets A, Vodolazskiy V, Rumyantsev A, Pokataev I, Orlova R, Volkova M, Tsimafeyeu I. Zukov R, et al. Among authors: sultanbaev a. BJU Int. 2025 Aug 28. doi: 10.1111/bju.16921. Online ahead of print. BJU Int. 2025. PMID: 40878239 No abstract available.
Clinical and Morphological Features of ER-Positive HER2-Negative Breast Tumors with PIK3CA Mutations in Russian Patients.
Sokolova TN, Yanus GA, Aleksakhina SN, Belysheva YV, Chernyakova AP, Zharnakova YS, Nikitina AS, Stebneva TM, Martianov AS, Goryainova AY, Gluzman MI, Orlova RV, Stukan' AI, Zyuzyukina AV, Zukov RA, Korzun PR, Binnatova JO, Abuzova AS, Murunova YN, Sultanbaev AV, Vorobeva EN, Mikhaevich LM, Pyliv VN, Lysenko AN, Khachmamuk ZK, Kozlov AE, Bakharev SY, Parsyan SG, Rossokha EI, Osidze LD, Shumskaya IS, Agaeva AV, Kasmynina TA, Klimenko VV, Akhmetgareeva KT, Vakhitova AA, Chakhkieva MD, Dmitriev VN, Bakshun YI, Vasiliev AE, Gasimly DD, Kravchenko NA, Maksimov DA, Nesterova AI, Sharvashidze IO, Gadzaova CK, Rakhmankulova GG, Khamgokov ZM, Amirkhanova IK, Bembeeva LV, Vladimirov VI, Petrenko OL, Ruskova NG, Serikova EL, Subbotina KS, Tkachenko SA, Chang VL, Erdniev SP, Barbara VS, Vasilevskaya AV, Mikheeva YV, Popova NO, Fateeva AV, Yukalchuk DY, Grechkina AA, Musayeva KS, Odintsova SV, Khabibulaeva PI, Khlobystina AG, Shvaiko KA, Basova EA, Bogomolova IA, Bolieva MB, Goldberg VE, Kibisheva MV, Menshikov KV, Ryazanov DV, Udalova YA, Shkradyuk AV, Khabriev IM, Kirtbaya DV, Degtyarev AM, Epkhiev AA, Tyugina YA, Murachuev MA, Stelmakh AS, Iyevleva AG, Imyanitov EN. Sokolova TN, et al. Among authors: sultanbaev av. Cancers (Basel). 2025 May 30;17(11):1833. doi: 10.3390/cancers17111833. Cancers (Basel). 2025. PMID: 40507317 Free PMC article.
11 results